Technology | 2018.12.10
Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models
- genOway to acquire exclusive rights to Merck\'s foundational genome-editing patents to produce, sell rodent models - New technologies and solutions to be developed using CRISPR/Cas9 to accelerate delivery of better drugs to patients DARMSTADT, Germany, Dec. 10, 2018 /PRNewswire/ --...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]p-rodent-models-878140782.html
